Endologix, Inc.

Endologix Launches the Powerlink System in Japan

Published in Hospital Law Weekly, February 28th, 2008

Endologix, Inc. (Nasdaq: ELGX), the developer and manufacturer of the Powerlink(R) System for the minimally invasive treatment of abdominal aortic aneurysms (AAA), announced that it has received notice of Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) and will soon be initiating Powerlink System product shipments to Japan.

"We are delighted with this approval, which marks the successful culmination of our efforts with the Japanese regulatory agency," said Paul McCormick, president and chief executive officer of Endologix. "We will begin by shipping an initial stocking order this month to our Japanese distributor COSMOTEC Co. Ltd. and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Law Weekly

Source: Hospital Law Weekly (2008-02-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry